As the deadlines for the US Drug Supply Chain Security Act (DSCSA) and the Falsified Medicines Directive (FMD) near, pharma businesses should be prioritising the validation of their solutions. Here, Lauren Catalano, technical services manager at Sharp Services, offers guidance on creating a best practice approach for implementing serialisation and packaging line and site readiness.
Best practices
Engaging with complexity